Management:

Mark Nedelman, President & CEO since 2010, has over 20 years experience in both contract research and pharmaceutical firms.  Over a 10 year period, Mark built Primedica Corporation’s Pharmacology and Experimental Surgery program to $18MM in revenue and led the Interventional and Surgical Services Group at Charles River Laboratories to $26MM annual revenue.  Earlier in his career, he led preclinical development efforts on several first-in-class drugs at Centocor.

Peter Glick, Chairman, is a serial entrepreneur and life sciences investor.  As President of Primedica Corporation, he led a preclinical CRO to revenues of $72MM and a sale to Charles River Laboratories.  As CEO of Cohesive Technologies, he led the placement of hundreds of advanced chromatography systems into high throughput laboratories and a sale to Thermo Fisher Scientific.  He is currently Chairman of Agilux Laboratories and Blue Sky Biotech, and has served as a General Partner at Ampersand Ventures. 

Craig Ferris, PhD, CSO and Co-Founder, is a professor of Psychology and Pharmaceutical Sciences at Northeastern University and Director of its Center for Translational Neuroimaging (CTNI). Prior to his appointments at Northeastern, he was Professor of Psychiatry and Physiology and Director of the Center for Comparative Neuroimaging at the University of Massachusetts Medical School.